Ginkgo Bioworks Holdings Inc (DNA) has a current stock price of $13.26. During the previous trading session, the stock witnessed a notable rise, reaching a high of $16.0 after opening at $13.26. The stock’s low for the day was $6.0, and it eventually closed at $11.56.
Ginkgo Bioworks Holdings Inc had a pretty favorable run when it comes to the market performance. Over the past year, the company’s stock reached a high of $16.85 on 02/06/25, while the lowest price during the same period was $5.00 on 04/04/25.
52-week price history of DNA Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Ginkgo Bioworks Holdings Inc’s current trading price is -21.31% away from its 52-week high, while its distance from the 52-week low is 165.20%. The stock’s price range for this period has remained between $5.00 and $16.85. The Healthcare sector company’s shares managed to surpass a trading volume of around 2.43 million for the day, which was noticeably higher compared to the shares’ average daily volume of 1.46 million over the last three months.
Financial Performance and Market Capitalization
Ginkgo Bioworks Holdings Inc (DNA) has experienced a quarterly rise of 63.30% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 778.27M and boasts a workforce of 834 employees.
Analysts’ Ratings For Ginkgo Bioworks Holdings Inc
As of right now, 1 analyst is rating Ginkgo Bioworks Holdings Inc as a BUY, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 2 of them gave the stock UNDERWEIGHT rating, and 1 analyst is rating the stock as SELL.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 9.04, with a change in price of +6.09. Similarly, Ginkgo Bioworks Holdings Inc recorded 1,437,607 in trading volume during the last 100 days, posting a change of +84.94%.
DNA Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for DNA stands at 0.70. Similarly, the long-term debt-to-equity ratio is also 0.70.
DNA Stock Stochastic Average
As of today, the raw stochastic average of Ginkgo Bioworks Holdings Inc over the last 50 days is at 73.57%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 62.41%. Further, the company’s Stochastic %K and %D values for the last 20 days were 47.16% and 47.50%, respectively.
DNA Stock Price Performance Analysis
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The index has shown a price gain of 22.69% this year. Over the last six months, there has been a weaker performance of 7.11%. The price of DNA fallen by 40.62% during the last 30 days period. For the last 5-days stocks have slided -5.01%.
